Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chmp
Pharma
Europe's CHMP reverses endorsement of Amgen's Tavneos
The CHMP has now determined that the Advocate study was “conducted in breach of good clinical practice (GCP) principles,” the EU agency said.
Fraiser Kansteiner
Jun 26, 2026 11:07am
Regulatory tracker: Rubraca scores full prostate cancer approval
Dec 18, 2025 2:45pm
EU regulators endorse meds from BMS, J&J, Eisai and more
Nov 15, 2024 10:05am
PTC gets another chance to keep Translarna's EU authorization
May 20, 2024 8:58am
Amylyx's ALS drug Albrioza rebuffed by EU regulator—again
Oct 13, 2023 11:24am
Mirati's flagship KRAS inhibitor Krazati gets rebuffed in Europe
Jul 21, 2023 12:20pm
